Design, expression, and characterization of a novel targeted plectasin against methicillin-resistant Staphylococcus aureus.
about
Biotechnical paving of recombinant enterocin A as the candidate of anti-Listeria agent.Optimization of expression conditions for a novel NZ2114-derived antimicrobial peptide-MP1102 under the control of the GAP promoter in Pichia pastoris X-33Design and pharmacodynamics of recombinant NZ2114 histidine mutants with improved activity against methicillin-resistant Staphylococcus aureus.Production of human lactoferrin and lysozyme in the milk of transgenic dairy animals: past, present, and future.Terpenoid bioactive compound from Streptomyces rochei (M32): taxonomy, fermentation and biological activities.Fungal proteinaceous compounds with multiple biological activities.Molecular chaperones (TrxA, SUMO, Intein, and GST) mediating expression, purification, and antimicrobial activity assays of plectasin in Escherichia coli.Antiviral cationic peptides as a strategy for innovation in global health therapeutics for dengue virus: high yield production of the biologically active recombinant plectasin peptide.In vitro and in vivo characterization of a new recombinant antimicrobial peptide, MP1102, against methicillin-resistant Staphylococcus aureus.High expression of a plectasin-derived peptide NZ2114 in Pichia pastoris and its pharmacodynamics, postantibiotic and synergy against Staphylococcus aureus.A dual mechanism involved in membrane and nucleic acid disruption of AvBD103b, a new avian defensin from the king penguin, against Salmonella enteritidis CVCC3377.Recombinant production of the antimicrobial peptide NZ17074 in Pichia pastoris using SUMO3 as a fusion partner.High-level expression, purification and characterisation of porcine β-defensin 2 in Pichia pastoris and its potential as a cost-efficient growth promoter in porcine feed.Specifically targeted antimicrobial peptides: A new and promising avenue in selective antimicrobial therapy.Classes, Databases, and Prediction Methods of Pharmaceutically and Commercially Important Cystine-Stabilized Peptides.
P2860
Q34161694-C4334802-0CA5-4D67-B18A-F0F8F56DBD1AQ35215598-D5735166-B3E7-4A6B-86EB-7EAD6E4E416AQ37660448-F138C38F-1BB8-4154-927B-5B61D4E4D39EQ38522594-91CD120C-3DA6-4CB5-9048-1320ED5BC371Q38750061-8BCF024B-36C0-4F79-A7D5-5F7B4DAC8BF4Q38874929-11AA59A2-A47F-47F5-846A-9C2B8E3F92C8Q38942371-F59A647C-666B-42A6-9BC8-F4A2687AE744Q40234350-BE2EB44C-8C4E-4B84-8678-6F1A2D81961DQ41522714-4D3DAA4D-E7EF-4956-A959-0F14EDB207E0Q45072518-560527C4-D29D-4E7E-9534-A5307B109608Q49996755-3B6B20D6-C63F-46BA-ACC5-9A476EED230BQ50000791-328A4C14-B8C4-4144-A14C-BBCCC948058DQ50002007-FCD45063-3212-42CD-9D9D-0FFF288B7470Q55327459-CD4FFC5B-3145-489A-940C-94576AAFBD92Q55515270-9DC7A8E2-E880-4FBE-9E02-ACF7FC68D82C
P2860
Design, expression, and characterization of a novel targeted plectasin against methicillin-resistant Staphylococcus aureus.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Design, expression, and charac ...... sistant Staphylococcus aureus.
@en
Design, expression, and charac ...... sistant Staphylococcus aureus.
@nl
type
label
Design, expression, and charac ...... sistant Staphylococcus aureus.
@en
Design, expression, and charac ...... sistant Staphylococcus aureus.
@nl
prefLabel
Design, expression, and charac ...... sistant Staphylococcus aureus.
@en
Design, expression, and charac ...... sistant Staphylococcus aureus.
@nl
P2093
P2860
P1476
Design, expression, and charac ...... sistant Staphylococcus aureus.
@en
P2093
Jianhua Wang
Xiaoyuan Hu
Xiumin Wang
Yalin Yang
Yong Zhang
P2860
P2888
P304
P356
10.1007/S00253-012-4508-Z
P407
P577
2012-10-25T00:00:00Z